BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20570624)

  • 61. Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype-matched ductal and lobular carcinomas.
    Lopez-Garcia MA; Geyer FC; Natrajan R; Kreike B; Mackay A; Grigoriadis A; Reis-Filho JS; Weigelt B
    J Pathol; 2010 Sep; 222(1):64-75. PubMed ID: 20593406
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up.
    Chamalidou C; Fohlin H; Albertsson P; Arnesson LG; Einbeigi Z; Holmberg E; Nordenskjöld A; Nordenskjöld B; Karlsson P; Linderholm B;
    Breast; 2021 Oct; 59():294-300. PubMed ID: 34388695
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of autophagy related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
    Cha YJ; Kim YH; Cho NH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(6):3389-98. PubMed ID: 25031766
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
    Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
    J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy.
    Wong H; Lau S; Cheung P; Wong TT; Parker A; Yau T; Epstein RJ
    BMC Cancer; 2014 Nov; 14():826. PubMed ID: 25385074
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Heterogeneity in risk factors for ductal and lobular breast carcinomas: A case-control study.
    Dianatinasab M; Fararouei M; Daneshi N; Rezaian S; Mohammadianpanah M; Chaman R; Ghiasvand R
    Int J Cancer; 2019 Dec; 145(11):2917-2925. PubMed ID: 30719718
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
    Moran MS; Yang Q; Haffty BG
    Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.
    Truin W; Vugts G; Roumen RM; Maaskant-Braat AJ; Nieuwenhuijzen GA; van der Heiden-van der Loo M; Tjan-Heijnen VC; Voogd AC
    Ann Surg Oncol; 2016 Jan; 23(1):51-7. PubMed ID: 25980321
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast Carcinoma.
    Sreekumar S; Levine KM; Sikora MJ; Chen J; Tasdemir N; Carter D; Dabbs DJ; Meier C; Basudan A; Boone D; McAuliffe PF; Jankowitz RC; Lee AV; Atkinson JM; Oesterreich S
    Endocrinology; 2020 Sep; 161(9):. PubMed ID: 32609836
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin.
    Braunstein LZ; Brock JE; Chen YH; Truong L; Russo AL; Arvold ND; Harris JR
    Breast Cancer Res Treat; 2015 Jan; 149(2):555-64. PubMed ID: 25604797
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analysis of prognosis in different subtypes of invasive lobular carcinoma using the Japanese National Cancer Database-Breast Cancer Registry.
    Adachi Y; Asaga S; Kumamaru H; Kinugawa N; Sagara Y; Niikura N; Jinno H; Saji S; Toi M
    Breast Cancer Res Treat; 2023 Oct; 201(3):397-408. PubMed ID: 37479943
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Preoperative MRT of the breast in invasive lobular carcinoma in comparison with invasive ductal carcinoma].
    Diekmann F; Diekmann S; Beljavskaja M; Bick U; Taupitz M; Blohmer JU; Winzer KJ; Hamm B
    Rofo; 2004 Apr; 176(4):544-9. PubMed ID: 15088179
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.
    Adachi Y; Sawaki M; Hattori M; Yoshimura A; Gondo N; Kotani H; Iwase M; Kataoka A; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Oze I; Iwata H
    Breast Cancer; 2018 Sep; 25(5):560-565. PubMed ID: 29536376
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Invasive lobular carcinoma: an understudied emergent subtype of breast cancer.
    Mouabbi JA; Hassan A; Lim B; Hortobagyi GN; Tripathy D; Layman RM
    Breast Cancer Res Treat; 2022 Jun; 193(2):253-264. PubMed ID: 35347549
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of sarcosine metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.
    Cha YJ; Jung WH; Cho NH; Koo JS
    Yonsei Med J; 2015 May; 56(3):598-607. PubMed ID: 25837163
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lack of CD151/integrin α3β1 complex is predictive of poor outcome in node-negative lobular breast carcinoma: opposing roles of CD151 in invasive lobular and ductal breast cancers.
    Romanska HM; Potemski P; Krakowska M; Mieszkowska M; Chaudhri S; Kordek R; Kubiak R; Speirs V; Hanby AM; Sadej R; Berditchevski F
    Br J Cancer; 2015 Nov; 113(9):1350-7. PubMed ID: 26418423
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinicopathological Features and Outcomes Comparing Patients With Invasive Ductal and Lobular Breast Cancer.
    Oesterreich S; Nasrazadani A; Zou J; Carleton N; Onger T; Wright MD; Li Y; Demanelis K; Ramaswamy B; Tseng G; Lee AV; Williams N; Kruse M
    J Natl Cancer Inst; 2022 Nov; 114(11):1511-1522. PubMed ID: 36239760
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons.
    Leonardi MC; Maisonneuve P; Mastropasqua MG; Cattani F; Fanetti G; Morra A; Lazzari R; Bazzani F; Caputo M; Rotmensz N; Gerardi MA; Ricotti R; Enrica Galimberti V; Veronesi P; Dicuonzo S; Viale G; Jereczek-Fossa BA; Orecchia R
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):173-181. PubMed ID: 28816144
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Genetic alterations in lobular breast cancer by comparative genomic hybridization.
    Nishizaki T; Chew K; Chu L; Isola J; Kallioniemi A; Weidner N; Waldman FM
    Int J Cancer; 1997 Oct; 74(5):513-7. PubMed ID: 9355973
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ultrasonographic findings of invasive lobular carcinoma differentiation of invasive lobular carcinoma from invasive ductal carcinoma by ultrasonography.
    Ohta T; Tsujimoto F; Nakajima Y; Fukuda M; Takag M
    Breast Cancer; 2005; 12(4):304-11. PubMed ID: 16286911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.